Markets:

Overview

News

Currencies

International

Treasuries

Aerie Pharmaceuticals, Inc. - Common Stock (NQ:AERI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aerie Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 16, 2021

Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump ↗

September 16, 2021

Midway through trading Thursday, the Dow traded down 0.74% to 34,557.75 while the NASDAQ fell 0.67% to 15,060.25. The S&P also fell, dropping 0.79% to 4,445.34. The U.S. has...

Via Benzinga

Topics Stocks

38 Stocks Moving In Thursday's Mid-Day Session ↗

September 16, 2021

Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS...

Via Benzinga

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet ↗

September 16, 2021

A study in eye-disease treatment missed its mark, leading this biotech stock to dive.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Down; US Retail Sales Unexpectedly Increase in August ↗

September 16, 2021

Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also fell, dropping 0.62% to 4,453.04. The U.S...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 16, 2021

Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

September 16, 2021

Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as the most-discussed stock on Reddit’s r/...

Via Benzinga

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial ↗

September 16, 2021

Aerie Pharmaceuticals Inc (NASDAQ: AERI) announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 15, 2021

Gainers Larimar Therapeutics (NASDAQ:

Via Benzinga

Looking into Aerie Pharmaceuticals's Return on Capital Employed ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, Aerie Pharmaceuticals (NASDAQ:AERI) posted sales of $27.18 million. Earnings were up 7.94%, but Aerie Pharmaceuticals...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 10, 2021

Gainers CohBar (NASDAQ:CWBR) shares incr...

Via Benzinga

Aerie Pharmaceuticals, inc (AERI) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

AERI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

18 Key Biopharma Catalysts To Keep An Eye On In Q3 ↗

July 10, 2021

Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the...

Via Talk Markets

18 Key Biopharma Catalysts To Keep An Eye On In Q3 ↗

July 10, 2021

Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

14 Biotech Stocks To Watch Over The Next 6 Months ↗

June 23, 2021

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Aerie Pharmaceuticals, Inc. - Common Stock (NQ:AERI)

Headline News about Aerie Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today